Niagen Bioscience Inc

NASDAQ: NAGE · Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.00
-0.10%
After-hours: Aug 15, 2025, 06:19 PM EDT

Niagen Bioscience Inc Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
116.3M 107.92M 99.6M 91.67M 85.58M 83.17M 83.57M 83.37M 80.94M 77.35M 72.05M 68.81M 69.06M 70.03M 67.45M 65.14M 62.01M 59.59M
Cost of Revenue
42.31M 40.46M 38.01M 35.34M 33.53M 32.45M 32.79M 33.51M 32.84M 31.56M 29.25M 27.16M 27.04M 27.24M 25.96M 25.09M 24.09M 23.4M
Gross Profit
73.99M 67.46M 61.59M 56.33M 52.05M 50.72M 50.78M 49.86M 48.1M 45.78M 42.8M 41.65M 42.02M 42.79M 41.49M 40.04M 37.92M 36.2M
Operating Income
16.67M 13.23M 7.73M 447K -2.3M -4.36M -5.6M -6.88M -8.79M -12.86M -18.63M -22.5M -28.28M -27.44M -27.07M -27.84M -23.19M -21.33M
Interest Income
1.66M 1.35M 1.13M 1.04M 950K 834K 661K 379K 191K 66K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
18.33M 14.58M 8.86M 1.49M -1.35M -3.53M -4.94M -6.47M -6.5M -10.7M -16.54M -20.45M -28.32M -27.49M -27.13M -27.9M -23.26M -21.4M
Net Income
17.73M 14.11M 8.55M 1.49M -1.35M -3.53M -4.94M -6.47M -6.5M -10.7M -16.54M -20.45M -28.32M -27.49M -27.13M -27.9M -23.26M -21.4M
Selling & General & Admin
51.89M 49.05M 47.84M 50.02M 48.55M 49.22M 51.42M 51.66M 51.83M 53.71M 56.6M 59.56M 65.93M 66.11M 64.73M 64.1M 57.49M 54.01M
Research & Development
5.43M 5.18M 6.02M 5.86M 5.81M 5.86M 4.96M 5.08M 5.06M 4.94M 4.83M 4.59M 4.36M 4.12M 3.83M 3.78M 3.62M 3.51M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
57.32M 54.23M 53.86M 55.88M 54.36M 55.08M 56.38M 56.73M 56.89M 58.65M 61.42M 64.15M 70.3M 70.23M 68.56M 67.88M 61.11M 57.52M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 5K 15K 23K 23K 33K 35K 46K 62K 66K 78K
Selling & Marketing Expenses
32.08M 30.85M 29.47M 27.27M 26.26M 25.3M 26.44M 26.11M 25.94M 27.95M 28.31M 30.77M 32.12M 30.33M 28.35M 26.03M 24.03M 22.76M
Cost & Expenses
99.63M 94.7M 91.87M 91.22M 87.89M 87.53M 89.17M 90.25M 89.73M 90.21M 90.68M 91.31M 97.33M 97.47M 94.52M 92.97M 85.2M 80.92M
Income Tax Expense
601K 473K 305K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
79.25M 77.81M 76.94M 93.9M 75.56M 75.23M 72.89M 75.05M 73.03M 74.8M 73.88M 68.34M 68.34M 68.31M 68.3M 68.24M 67.99M 64.16M
Shares Outstanding (Diluted)
86.24M 83.23M 81.68M 77.77M 75.56M 75.23M 75.11M 75.05M 74.97M 74.8M 73.88M 68.34M 68.34M 68.31M 68.3M 68.24M 67.99M 64.16M
EPS (Basic)
0.22 0.18 0.11 0.01 -0.02 -0.05 -0.07 -0.09 -0.09 -0.15 -0.24 -0.3 -0.41 -0.4 -0.41 -0.43 -0.37 -0.35
EPS (Diluted)
0.21 0.17 0.11 0.02 -0.02 -0.05 -0.07 -0.09 -0.09 -0.15 -0.24 -0.3 -0.41 -0.4 -0.41 -0.43 -0.37 -0.35
EBITDA
18.12M 14.69M 9.21M 1.95M -721K -2.71M -3.89M -7.17M -9.09M -13.17M -18.83M -20.68M -26.49M -25.68M -25.45M -26.2M -21.6M -19.77M
EBIT
16.67M 13.23M 7.73M 447K -2.3M -4.36M -5.6M -8.96M -10.88M -14.95M -20.71M -22.5M -28.28M -27.44M -27.07M -27.84M -23.19M -21.33M
Depreciation & Amortization
1.45M 1.46M 1.48M 1.5M 1.58M 1.66M 1.71M 1.79M 1.79M 1.77M 1.88M 1.82M 1.78M 1.77M 1.63M 1.63M 1.59M 1.55M